Active, not recruitingNCT05186857

Metabolome and Microbiome Impact on Acute GVHD in Recipients of Hematopoietic Transplant

Studying Graft versus host disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Principal Investigator
Ildefonso Espigado, PhD, M.D
Seville University, Dep. of Medicine. Virgen del Rocío/Virgen Macarena Hospitals, Instituto de Investigación Biomédica de Sevilla / CSIC, Seville, Spain
Enrollment
88 target
Eligibility
1-100 years · All sexes
Timeline
2023 – 2026

Study locations (9)

Collaborators

Instituto de Salud Carlos III

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05186857 on ClinicalTrials.gov

Other trials for Graft versus host disease

Additional recruiting or active studies for the same condition.

See all trials for Graft versus host disease →

← Back to all trials